| Outcome Measures: |
Primary: Change from baseline to Visit 6/Early Termination (ET) in serum phosphorous., 8 weeks|Frequency of treatment-emergent adverse events (AEs) and serious adverse events (SAEs), changes in laboratory parameters, and changes in vital signs., 11 weeks | Secondary: Change from baseline to Visit 6/ET in serum lipids (total cholesterol and LDL-cholesterol)., 8 weeks
|
| Locations: |
Peking Union Medical College Hospital, Beijing, China|Peking University First Hospital, Beijing, China|Sichuan Provincial People's Hospital, Chengdu, China|West China Hospital, Chengdu, China|Southwest Hospital, Chongqing, China|Guangzhou First Municipal People's Hospital, Guangzhou, China|Nanfang Hospital, Guangzhou, China|Sun Yat-Sen University School of Medicine 1st Affiliated Hospital, Guangzhou, China|Zhejiang University School of Medicine 1st Affiliated Hospital, Hangzhou, China|Jiangsu Province Hospital, Nanjing, China|Zhongda Hospital of Southeast University, Nanjing, China|Qingdao Municipal Hospital, Qingdao, China|Changzheng Hospital, Shanghai, China|Renji Hospital, Shanghai, China|Shanghai Ruijin Hospital, Shanghai, China|Xinhua Hospital, Shanghai, China|Zhongshan Hospital, Shanghai, China|Wenzhou College of Medicine 1st Affiliated Hospital, Wenzhou, China
|
